Pages that link to "Q28469333"

The following pages link to A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru (Q28469333):

Displaying 30 items.

• Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malariaedit (Q21032449) (← links)
• Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria (Q24201077) (← links)
• Artemisinin-based combination therapy for treating uncomplicated malaria (Q24241785) (← links)
• The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data (Q26822489) (← links)
• Antimalarial efficacy of piperaquine-based antimalarial combination therapies: facts and uncertainties (Q26866187) (← links)
• A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial (Q28477853) (← links)
• Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis (Q33489551) (← links)
• Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial (Q33516563) (← links)
• Protective efficacy of malaria case management and intermittent preventive treatment for preventing malaria mortality in children: a systematic review for the Lives Saved Tool (Q33875677) (← links)
• Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination (Q34177472) (← links)
• The story of artesunate-mefloquine (ASMQ), innovative partnerships in drug development: case study (Q34329292) (← links)
• A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos (Q34341784) (← links)
• Development, evaluation, and application of an in silico model for antimalarial drug treatment and failure. (Q35065737) (← links)
• Monitoring the efficacy and safety of three artemisinin based-combinations therapies in Senegal: results from two years surveillance (Q35071899) (← links)
• Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria (Q35598379) (← links)
• Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum (Q35834198) (← links)
• The global pipeline of new medicines for the control and elimination of malaria (Q36320249) (← links)
• In vitro sensitivities of Plasmodium falciparum isolates from the China-Myanmar border to piperaquine and association with polymorphisms in candidate genes (Q36757694) (← links)
• Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda (Q37263818) (← links)
• Existing antimalarial agents and malaria-treatment strategies (Q37492591) (← links)
• Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies (Q38065917) (← links)
• Plasmodium falciparum gametocytes: with a view to a kill. (Q38129536) (← links)
• Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination (Q38245842) (← links)
• Failure of dihydroartemisinin-piperaquine treatment of uncomplicated Plasmodium falciparum malaria in a traveller coming from Ethiopia (Q39025693) (← links)
• Efficacy and safety of artesunate-mefloquine therapy for treating uncomplicated Plasmodium falciparum malaria: systematic review and meta-analysis (Q39063353) (← links)
• Absence of association between piperaquine in vitro responses and polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe genes in Plasmodium falciparum (Q41935621) (← links)
• Accelerating to Zero: Strategies to Eliminate Malaria in the Peruvian Amazon. (Q46163259) (← links)
• Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. (Q52615236) (← links)
• Recent updates in the discovery and development of novel antimalarial drug candidates (Q56403247) (← links)
• Sub-acute toxicological study of artemisinin-piperaquine tablets in rhesus monkeys (Q90456358) (← links)